Theratechnologies
THTX
THTX was delisted on the 25th of September, 2025.
49 hedge funds and large institutions have $28.2M invested in Theratechnologies in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
57% more capital invested
Capital invested by funds: $18M → $28.2M (+$10.2M)
26% more funds holding
Funds holding: 39 → 49 (+10)
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
1.81% less ownership
Funds ownership: 27.77% → 25.96% (-1.8%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$400K |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$368K |
| 3 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$325K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$263K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.34M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$598K |
| 3 |
WANY
Wealthspire Advisors (New York)
New York
|
-$49K |
| 4 |
JP Morgan Chase
New York
|
-$48.9K |
| 5 |
STA
Summit Trail Advisors
New York
|
-$46.3K |
THTX Hedge Fund Activity: Q2 2025 in Review
49 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q2 2025, worth a combined $28.2M — up 57% from $18M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new THTX positions and 4 closed out — a net gain of 10 holders — while 10 added to existing stakes and 8 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $400K. The largest seller was Morgan Stanley, cutting an estimated $3.34M.
- 49 institutional investors held Theratechnologies (THTX) as of Q2 2025, up from 39 in Q1 2025.
- Funds reported $28.2M of Theratechnologies stock for Q2 2025, up 57% quarter-over-quarter.
- 14 funds opened new Theratechnologies positions in Q2 2025 and 4 closed out, a net change of +10 holders.
- The largest Theratechnologies buyer in Q2 2025 was Stonepine Capital Management, an estimated $400K added.
- The largest Theratechnologies seller in Q2 2025 was Morgan Stanley, an estimated $3.34M sold.
Based on aggregated 13F filings for Q2 2025.